1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
Global Cell Therapy Market Outlook 2020

Global Cell Therapy Market Outlook 2020

  • May 2015
  • 550 pages
  • ID: 4397220
  • Format: PDF
  • By Kuick Research

Summary

Table of Contents

Pharmaceutical companies are actively looking for different modalities which could help in generating more revenues by competing with existing products. Traditional therapeutic have modest safety and efficacy levels and newer options are required to overcome their shortcomings. In this quest, they have focused upon cell therapy which holds both pharmacological and commercialization potential. Their utilization for therapeutic treatment of various diseases have been identified and used them successfully in past few decades. Various new cell therapy modalities are being discovered which are at different stages of clinical trials. They are expected to prove their safety and efficacy levels before entering in global market in coming years. Myriad of innovative cell therapies are under development which are expected to the change the way diseases are treated. Some of the therapeutics are widely accepted and they have already entered in clinical trials, while others are expected to face stringent regulations.

Cell therapies have been widely promoted by pharmaceutical companies as cure for all diseases. Especially, the concept of stem cell therapy has been promoted as panacea that can effectively tackle majority of ailments. But investigators have found that they are far from real scenario in which most of the underlying principles of stem cell therapy are not understood. During experimentation, investigators have found tumor formation in different parts of body of test subject. Microscopic examination revealed that it is not tumor nor cancerous cell accumulation, such thing has never been reported. In some cases, cancerous condition was found to be developed after administration of stem cells. These events show that server life threatening side effects could be developed without offering pharmacological benefits. Pharmaceutical companies need diligence because cells therapies are relatively new discovery and much work has to be done before their successful commercialization.

Utilization of cell therapy in tissue and regenerative medicine is expected to have huge marketing potential. Presently, there are no other options which could help in the growth of deregulated organs. Several therapeutic molecules are present in this segment but they are unable to form new tissue or sometimes organ transplant is required. It may be very complicated as suitable donor is required and process is quite invasive due to which high mortality rates are observed. On the other hand, cell therapy treatments are expected to overcome these issues which will increase their acceptance levels leading to higher sales. It could be applied for several categories that increase their applicability and commercialization prospects. Some categories like skin graft has been introduced across the globe for skin related issues. Presently, only few applications like severe burns are treated with their assistance but in future its applicability for cosmetic purposes are expected to be extended. In this way, their commercialization potential is expected to be improved increased due to increased number of indications.

Cell therapies are becoming competent with time and their utilization in large number of indications have made them an indispensible part of pharmaceutical industry. Significant investments in research and development segment along with years of data are helping in introduction of innovative products. However, they are quite new for pharmaceutical industry and their long-term effect is not known. It may offer hindrance but their superior pharmacological efficacy is going to promote their usage across the globe. It is at nascent stages but holds promise for future generations which are expected to observe boost in cell therapy products. Glitches in manufacturing and large scale production are needed to be solved in coming years. Many significant results have been achieved due to which confidence of investors, investigators, physicians and patients have increased in cell therapies. All these development shows that cell therapeutics are expected to generate significant revenues across the globe.



" Global Cell Therapy Market Outlook 2020" Report Highlight:

Introduction & Classification of Cell Therapy
Role of Stem Cells in Cell Therapy
Global Cell Therapy Market Analysis
Global Cell Therapy Clinical Pipeline by Country, Indication & Phase
Marketed Cell Therapy Clinical Insight by Brand Name, Company & Indication
Global Cell Therapy Clinical Pipeline: 262 Cell Therapies Drugs
Marketed Cell Therapies: 13


Marketed Cell Therapy Clinical Insight by Brand Name, Company & Indication

Adipose Stem Cell Therapy (Adipocell®)
Allogeneic Cultured Keratinocytes & Fibroblasts (Gintuit®)
Angiogenic Cell Precursor Therapy (VesCell™)
Autologous Chondrocyte Implantation (ChondroCelect®)
Autologous Chondrocytes (BioCart™)
Autologous Cultured Chondrocyte Implant (Carticel®)
Autologous Cultured Chondrocytes (Chondrotransplant® DISC)
Matrix Characterised Autologous Cultured Chondrocytes (MACI™)
Azficel-T (Laviv®)
Human Skin Replacement for Burns (CellSpray®)
Leukocyte Cell Therapy (CureXcell™)
Sipuleucel-T (Provenge®)
T-Lymphocyte Cell Therapy (Immuncell-LC®)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Induced Pluripotent Stem Cell ((iPSC) Industry

Global Induced Pluripotent Stem Cell ((iPSC) Industry

  • $ 4950
  • October 2019

Induced Pluripotent Stem Cell ((iPSC) market worldwide is projected to grow by US$682.2 Million, driven by a compounded growth of 6.3%. Drug Development & Toxicology Testing, one of the segments analyzed ...

Precision Immunotherapy Innovations Transforming Human Health and Wellness

Precision Immunotherapy Innovations Transforming Human Health and Wellness

  • $ 4950
  • September 2019

There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases.Current study describes some of the recent advances in immunotherapy, mostly cancer.These ...

Global Cell Sorting Industry

Global Cell Sorting Industry

  • $ 5450
  • October 2019

Cell Sorting market worldwide is projected to grow by US$110.9 Million, driven by a compounded growth of 6.6%. Fluorescence-based Droplet Cell Sorting, one of the segments analyzed and sized in this study, ...

Colitis - Pipeline Review, H2 2019 $ 2000 September 2019


ref:plp2015

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on